For instance, if low CAV1 expression in cancer also causes high dependency on glucose over lipid metabolism as reported in non-cancer cells [52, 58], then it raises an attractive prospect of using CAV1 expression levels to stratify cancer patients into those that could benefit from either inhibitors of glucose or lipid metabolism. Here, CAV1 is linked to cancer.